E Wilbek
Impact in
- Physiology top 10%
- Sarcoidosis and Beryllium Toxicity Research
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology
Papers in
-
- Tuberculosis Research and Epidemiology 7
-
- Sarcoidosis and Beryllium Toxicity Research 5
- Co-authors
- H BrinckerO HorwitzPennifer Erickson
- Journals
- British Journal of Cancer (1 paper)Acta Medica Scandinavica (1 paper)PubMed (11 papers)
In The Last Decade
E Wilbek
9 papers receiving 386 citations
Peers
Comparison fields: 5 of 65
- Physiology 225
- Infectious Diseases 132
- Pulmonary and Respiratory Medicine 185
- Epidemiology 151
- Surgery 101
Countries citing papers authored by E Wilbek
This map shows the geographic impact of E Wilbek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Wilbek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Wilbek more than expected).
Fields of papers citing papers by E Wilbek
This network shows the impact of papers produced by E Wilbek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Wilbek. The network helps show where E Wilbek may publish in the future.
Co-authors
The 3 scholars most cited alongside E Wilbek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | [The epidemiology of sarcoidosis in Denmark]. | 1974 | 4 |
| 2 | [The incidence of malignant tumors in patients with sarcoidosis]. | 1974 | 16 |
| 3 | 1974 | 260 | |
| 4 | 1971 | 3 | |
| 5 | Epidemiological basis of tuberculosis eradication. 10. Longitudinal studies on the risk of tuberculosis in the general population of a low-prevalence area. | 1969 | 48 |
| 6 | [Risk of tuberculosis in a normal population]. | 1969 | 1 |
| 7 | Epidemiological studies on the extent of pulmonary lesions in Danish tuberculosis patients. | 1968 | 1 |
| 8 | Epidemiology of sarcoidosis in Denmark. | 1967 | 23 |
| 9 | Epidemiological basis of tuberculosis eradication. 4. The isoniazid trial in Greenland. | 1966 | 38 |
| 10 | 1964 | 1 | |
| 11 | Control of the efficacy of the Danish notification system for pulmonary tuberculosis. | 1960 | 4 |
| 12 | Epidemiological basis of tuberculosis eradication in an advanced country. | 1959 | 65 |
| 13 | [Consequences of changes in the epidemiology of tuberculosis; tuberculosis morbidity of the Danish population as a whole & of special groups]. | 1957 | 6 |
About E Wilbek
E Wilbek is a scholar working on Infectious Diseases, Physiology, Pulmonary and Respiratory Medicine, Epidemiology and Oncology, having authored 13 papers that have together received 470 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (7 papers), Sarcoidosis and Beryllium Toxicity Research (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Bacillus and Francisella bacterial research (2 papers), Global Cancer Incidence and Screening (1 paper), Pneumonia and Respiratory Infections (1 paper), Chronic Obstructive Pulmonary Disease (COPD) Research (1 paper) and Mycobacterium research and diagnosis (1 paper). The work is most often cited by research in Physiology (225 citations), Infectious Diseases (132 citations), Pulmonary and Respiratory Medicine (185 citations), Epidemiology (151 citations) and Surgery (101 citations). Frequent co-authors include H Brincker, O Horwitz and Pennifer Erickson. Their work appears in journals such as British Journal of Cancer, Acta Medica Scandinavica and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.